The Politics of Ambition: Law Schools, Healthcare, and Meatpacking in America
There’s something deeply American about the stories unfolding in Louisiana, Medicare offices, and the nation’s meatpacking plants. Each, in its own way, reflects the tension between ambition and reality, between what we want and what we can actually achieve. Let’s start with the law school saga in Louisiana, because it’s a perfect example of how personal ambition can collide with systemic inertia—and why that matters far beyond the Bayou State.
The Law School That May Never Be
Northwestern State University President Jimmy Genovese is pushing hard to establish North Louisiana’s first law school. On the surface, it’s a noble goal: expanding access to legal education in an underserved region. But dig deeper, and you’ll find a story of political maneuvering, unmet expectations, and the perils of overpromising.
What makes this particularly fascinating is how quickly the project has unraveled. Governor Jeff Landry, who reportedly floated the idea initially, has since backed away. Higher Education Commissioner Kim Hunter Reed refused to fast-track the proposal. Lawmakers are frustrated, and the Board of Regents hasn’t budged. Yet Genovese keeps promoting the school as if it’s a done deal.
Personally, I think this is a classic case of ambition outpacing practicality. Law schools are already facing declining enrollment and questions about their value in a changing legal market. Adding another one in a region that may not support it feels like a solution in search of a problem. What many people don’t realize is that opening a law school isn’t just about classrooms and textbooks—it’s about securing accreditation, attracting faculty, and ensuring graduates can find jobs. If you take a step back and think about it, this proposal feels more like a political play than a thoughtful investment in education.
Medicare’s Weighty Decision
Now, let’s shift gears to Medicare’s new coverage of GLP-1 weight-loss medications. Starting July 1, eligible beneficiaries can access drugs like Wegovy and Zepbound for a $50 monthly copay. This is a big deal—not just for public health, but for the pharmaceutical industry and the broader conversation about obesity treatment.
What this really suggests is that we’re finally starting to treat obesity as the chronic disease it is, rather than a moral failing. For decades, weight-loss medications have been stigmatized, underfunded, and excluded from insurance coverage. Medicare’s move is a step toward recognizing that obesity is complex, often tied to systemic issues like food insecurity and lack of access to healthcare.
But here’s where it gets interesting: these drugs are expensive, and their long-term effects aren’t fully understood. A detail that I find especially interesting is the temporary nature of the program—it’s a “demonstration” rather than a permanent policy. This raises a deeper question: Are we willing to invest in preventive care, or will we continue to treat obesity as a problem to be managed, not solved?
The Meatpacking Paradox
Finally, let’s talk about the Trump administration’s plan to support small and midsize meatpackers with up to $500 million. On the surface, it’s a move to stabilize beef supply, ease price pressure, and promote competition. But in my opinion, it’s also a political calculation aimed at rural voters and a response to growing antitrust scrutiny of industry giants like Tyson and JBS.
What makes this particularly fascinating is the timing. Beef prices are high, supplies are tight, and consumers are feeling the pinch. By funneling money to smaller players, the administration is positioning itself as a champion of the little guy. But here’s the catch: the largest meatpackers control the majority of the market. Without addressing their dominance, any attempt to stabilize the industry feels like a Band-Aid solution.
One thing that immediately stands out is the psychological aspect of this move. It’s not just about economics—it’s about perception. By excluding the big players, the administration is sending a message: “We’re on your side.” But if you take a step back and think about it, the real issue is the lack of competition in the first place. This program might help in the short term, but it doesn’t fix the underlying problem.
The Bigger Picture
If there’s one thread that ties these stories together, it’s the tension between ambition and reality. Whether it’s building a law school, expanding healthcare coverage, or stabilizing the meatpacking industry, each initiative reflects a desire to solve complex problems. But in each case, the execution falls short.
From my perspective, this is a symptom of a larger issue: our tendency to prioritize quick fixes over long-term solutions. We want results now, even if they’re not sustainable. We celebrate ambition, even when it’s misguided. And we often overlook the systemic barriers that make real change so difficult.
What this really suggests is that we need to rethink how we approach policy. Instead of chasing headlines, we should focus on building foundations—whether it’s investing in education, healthcare, or fair competition. It’s not glamorous, but it’s necessary.
As I reflect on these stories, I’m reminded of a quote from the writer Annie Dillard: ‘How we spend our days is, of course, how we spend our lives.’ The same could be said for how we approach our challenges. Are we spending our time and resources on projects that truly matter, or are we just chasing the next big idea? That’s the question these stories leave me with—and it’s one I think we all need to answer.
